Investing
315 Articles
Dividend aristocrats get plenty of attention, but most of the time the spotlight falls on the big names like Johnson…
Abbott Laboratories (NYSE: ABT | ABT Price Prediction) and Eli Lilly (NYSE: LLY) just reported Q3 earnings that highlight two…
Here are five Goldman Sachs stock picks that conservative growth and income investors should consider moving to for what could…
Founded in 1869, Goldman Sachs is the world’s second-largest investment bank by revenue and is ranked 55th on the Fortune…
Here are the four new stock additions to the Goldman Sachs Conviction List for October—all outstanding total return ideas for…
Over the past 11 years, I’ve built a portfolio centered on steady dividend payers, stocks that deliver reliable income quarter…
First, it was David Solomon from Goldman Sachs, then Jamie Dimon from J.P. Morgan, in less than a week, warning…
The SPDR S&P 500 ETF (NYSEMKT: SPY) is down 1.59% at 1:45 PM ET as U.S.- China trade tensions are…
It’s no secret that AI has captured the imagination of many growth oriented investors, which is a big reason why…
Abbott Laboratories (NYSE: ABT | ABT Price Prediction) is reporting before the market opens and we’ll be updating this article…
These five top Dividend Kings have posted massive double-digit total return figures so far this year and are Buy-rated by…
These four Dividend Aristocrats are far outperforming the S&P 500 so far this year. They still offer investors good entry…
Stifel recommends “defensive value” stocks for the remainder of 2025, and the firm has these five rated Buy.
The markets remain stuck in the doldrums, owing to tariffs, but appear to be coming off their lows of the…
AbbVie has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady…
Our top personal finance-related articles today. Your wallet will thank you later.